Viewing Study NCT04125693


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-02-23 @ 2:32 AM
Study NCT ID: NCT04125693
Status: COMPLETED
Last Update Posted: 2022-04-01
First Post: 2019-10-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Roll-over Study to Continue Treatment With the Investigational Drug Rogaratinib and to Further Test Its Safety
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module